Vasse M, Thibout D, Paysant J, Legrand E, Soria C, Crépin M
Laboratoire DIFEMA, Groupe de Recherche MERCI, Faculté de Médecine et Pharmacie de Rouen, 22 Bd Gambetta, 76183 Rouen Cedex, France.
Br J Cancer. 2001 Mar 23;84(6):802-7. doi: 10.1054/bjoc.2000.1648.
Sodium phenylacetate (NaPa), a non-toxic phenylalanine metabolite, has been shown to induce in vivo and in vitro cytostatic and antiproliferative effects on various cell types. In this work, we analysed the effect of NaPa on the invasiveness of breast cancer cell (MDA-MB-231, MCF-7 and MCF-7 ras). Using the highly invasive breast cancer cell line MDA-MB-231, we demonstrated that an 18-hour incubation with NaPa strongly inhibits the cell invasiveness through Matrigel (86% inhibition at 20 mM of NaPa). As cell invasiveness is greatly influenced by the expression of urokinase (u-PA) and its cell surface receptor (u-PAR) as well as the secretion of matrix metalloproteinases (MMP), we tested the effect of NaPa on these parameters. An 18-hour incubation with NaPa did not modify u-PA expression, either on MDA-MB-231 or on MCF-7 and MCF-7 ras cell lines, and induced a small u-PA decrease after 3 days of treatment of MDA-MB-321 with NaPa. In contrast, an 18 h incubation of MDA-MB-231 increased the expression of u-PAR and the secretion of MMP-9. As u-PAR is a ligand for vitronectin, a composant of the extracellular matrix, these data could explain the increased adhesion of MDA-MB-231 to vitronectin, while cell adhesivity of MCF-7 and MCF-7 ras was unmodified by NaPa treatment. NaPa induced also an increased expression of both Lymphocyte Function-Associated-1 (LFA-1) and Intercellular Adhesion Molecule-1 (ICAM-1), which was obvious from 18 hour incubation with NaPa for the MDA-MB-231 cells, but was delayed (3 days) for MCF-7 and MCF-7 ras. Only neutralizing antibodies against LFA-1 reversed the decreased invasiveness of NaPa-treated cells. Therefore we can conclude that the strong inhibition of MDA-MB-231 invasiveness is not due to a decrease in proteases involved in cell migration (u-PA and MMP) but could be related both to the modification of cell structure and an increased expression of adhesion molecules such as u-PAR and LFA-1.
苯乙酸钠(NaPa)是一种无毒的苯丙氨酸代谢产物,已被证明在体内和体外对多种细胞类型具有细胞抑制和抗增殖作用。在本研究中,我们分析了NaPa对乳腺癌细胞(MDA-MB-231、MCF-7和MCF-7 ras)侵袭性的影响。使用高侵袭性的乳腺癌细胞系MDA-MB-231,我们证明,用NaPa孵育18小时可强烈抑制细胞通过基质胶的侵袭能力(在20 mM NaPa时抑制率达86%)。由于细胞侵袭性受尿激酶(u-PA)及其细胞表面受体(u-PAR)的表达以及基质金属蛋白酶(MMP)分泌的极大影响,我们测试了NaPa对这些参数的作用。用NaPa孵育18小时,对MDA-MB-231、MCF-7和MCF-7 ras细胞系的u-PA表达均无影响,在用NaPa处理MDA-MB-321 3天后,u-PA略有下降。相反,用NaPa孵育MDA-MB-231 18小时可增加u-PAR的表达和MMP-9的分泌。由于u-PAR是细胞外基质成分玻连蛋白的配体,这些数据可以解释MDA-MB-231与玻连蛋白的黏附增加,而NaPa处理对MCF-7和MCF-7 ras的细胞黏附性无影响。NaPa还可诱导淋巴细胞功能相关抗原-1(LFA-1)和细胞间黏附分子-1(ICAM-1)的表达增加,这在MDA-MB-231细胞与NaPa孵育18小时后即很明显,但在MCF-7和MCF-7 ras细胞中延迟出现(3天)。只有抗LFA-1的中和抗体可逆转NaPa处理细胞侵袭性的降低。因此我们可以得出结论,MDA-MB-231侵袭性的强烈抑制并非由于参与细胞迁移的蛋白酶(u-PA和MMP)减少,而是可能与细胞结构的改变以及黏附分子如u-PAR和LFA-1表达的增加有关。